Altria Group Stock - Weekly review and sector comparison for tobacco majors

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 14:56 UTC. Details in the imprint.

Altria Group Inc. (US02209S1033) remains one of the highest-yielding tobacco stocks in the US market. The weekly picture is shaped less by big headlines and more by steady income expectations and ongoing regulation for cigarettes and reduced-risk products.

How Altria shares ended the week

Altria shares most recently changed hands around the upper half of their 12-month range, with a last indicated price of about $69 per share according to recent quote data. Daily moves this week were modest, without a single outsized session.

The stock continues to trade in line with its reputation as a defensive, income-oriented name rather than a high-volatility momentum play. That profile has kept short-term swings relatively contained even as broader equity indices remain more volatile.

Weekly review and sector comparison

Within the global tobacco peer group, Altria sits alongside British American Tobacco, Philip Morris International and Japan Tobacco as one of the large-cap incumbents. Compared with these peers, its revenue base is heavily concentrated in the US market.

Dividend yield remains a key differentiator in the weekly review, with Altria’s annual payout policy still targeting a high share of adjusted earnings. Many sector investors focus less on weekly price changes and more on the sustainability of that cash return profile.

How the company makes money

Altria generates the bulk of its revenue and profit from US sales of cigarettes under the Marlboro brand, complemented by smokeless tobacco and oral nicotine products. The group is gradually reallocating capital toward reduced-risk and smoke-free alternatives to offset long-term volume declines.

Where the stock trades today

The shares of Altria Group Inc. (US02209S1033) trade on the New York Stock Exchange at $69.25 as of 06/19/2026, 00:59 EDT.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.